Wu AM - Search Results

1

Minibodies and Multimodal Chromatography Methods: A Convergence of Challenge and Opportunity.

Gagnon P, Cheung CW, Lepin EJ, Wu AM, Sherman MA, Raubitschek AA, Yazaki PJ. Gagnon P, et al. Among authors: wu am. Bioprocess Int. 2010 Feb;8(2):26-35. Bioprocess Int. 2010. PMID: 21984873 Free PMC article.

2

Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

Hu S, Shively L, Raubitschek A, Sherman M, Williams LE, Wong JY, Shively JE, Wu AM. Hu S, et al. Among authors: wu am. Cancer Res. 1996 Jul 1;56(13):3055-61. Cancer Res. 1996. PMID: 8674062

3

Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies.

Williams LE, Liu A, Wu AM, Odom-Maryon T, Chai A, Raubitschek AA, Wong JY. Williams LE, et al. Among authors: wu am. Med Phys. 1995 Dec;22(12):2025-7. doi: 10.1118/1.597646. Med Phys. 1995. PMID: 8746707 No abstract available.

4

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.

Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, Hu SZ, Odom-Maryon T, Wong JY, Shively JE. Wu AM, et al. Immunotechnology. 1996 Feb;2(1):21-36. doi: 10.1016/1380-2933(95)00027-5. Immunotechnology. 1996. PMID: 9373325

5

Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.

Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA. Wong JY, et al. Among authors: wu am. J Nucl Med. 1997 Dec;38(12):1951-9. J Nucl Med. 1997. PMID: 9430476 Free article. Clinical Trial.

6

CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy.

Jensen M, Tan G, Forman S, Wu AM, Raubitschek A. Jensen M, et al. Among authors: wu am. Biol Blood Marrow Transplant. 1998;4(2):75-83. doi: 10.1053/bbmt.1998.v4.pm9763110. Biol Blood Marrow Transplant. 1998. PMID: 9763110 Free article.

7

Expression, purification, and characterization of a two domain carcinoembryonic antigen minigene (N-A3) in pichia pastoris. The essential role of the N-domain.

You YH, Hefta LJ, Yazaki PJ, Wu AM, Shively JE. You YH, et al. Among authors: wu am. Anticancer Res. 1998 Sep-Oct;18(5A):3193-201. Anticancer Res. 1998. PMID: 9858883

8

Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.

Wong JY, Chu DZ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE, Raubitschek AA. Wong JY, et al. Among authors: wu am. J Nucl Med. 1998 Dec;39(12):2097-104. J Nucl Med. 1998. PMID: 9867150 Free article. Clinical Trial.

9

Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.

Wong JY, Somlo G, Odom-Maryon T, Williams LE, Liu A, Yamauchi D, Wu AM, Yazaki P, Wilczynski S, Shively JE, Forman S, Doroshow JH, Raubitschek AA. Wong JY, et al. Among authors: wu am. Clin Cancer Res. 1999 Oct;5(10 Suppl):3224s-3231s. Clin Cancer Res. 1999. PMID: 10541368 Clinical Trial.

10

Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.

Tsai SW, Sun Y, Williams LE, Raubitschek AA, Wu AM, Shively JE. Tsai SW, et al. Among authors: wu am. Bioconjug Chem. 2000 May-Jun;11(3):327-34. doi: 10.1021/bc9901292. Bioconjug Chem. 2000. PMID: 10821648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

724 results

Search Page

Filters